NASDAQ : IRMD
-$0.65 (-0.71%)
NASDAQ
Roger E. Susi
Medical - Devices
Healthcare
IRMD
166
US
USD
0.00
9.46
9.46
6.45
0.69
$83.81M
13.50
11.46
46.77
1.95
$1.75
$22.48M
26.70%
34.45%
23.45%
20.05%
50.12
4.30
4.30
$120.00
$120.00
$120.00
3/5
2 Analysts
-23.99%
56.86
5/9
$77.56M
$114.98M
$13.23M
$29.25M
$1.12B
12.92
35.85
9.46
23.45%
20.18%
1.96%
2.12%
$17.97
23 days
| Name | Title |
|---|---|
| Chris Williamson | Executive Vice President of Continuous Improvement & Information Technology |
| John F. Glenn | Chief Financial Officer & Corporate Secretary |
| Lynn Neuhardt | Vice President of Research & Development |
| Randy Waddell | Vice President of Worldwide Sales & Marketing |
| Roger E. Susi | Founder, Chairman, Chief Executive Officer & President |
| Jeff Chiprin | Chief Commercial Officer |
| Matt Garner | Controller |
No votes yet today — be the first to share your view!
About IRadimed Corporation (NASDAQ:IRMD) Stock
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospita ... ls, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
iRadimed Q2 Earnings Call Highlights
2026-07-31 13:05:37
iRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked through the costs associated with an initial manufacturing ramp.
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
2026-07-31 12:43:16
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
2026-07-31 08:15:00
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025. Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026.
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
2026-07-24 16:15:00
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
2026-06-02 08:09:44
This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance.
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-20 08:30:00
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.
Frequently Asked Questions
What is the current IRadimed Corporation (IRMD) stock price?
IRadimed Corporation(NASDAQ:IRMD) stock price is $91.21 in the last trading session. During the trading session, IRMD stock reached the peak price of $107.9 while $67.51 was the lowest point it dropped to. The percentage change in IRMD stock occurred in the recent session was --0.71% while the dollar amount for the price change in IRMD stock was -$0.65.
IRMD's industry and sector of operation?
The NASDAQ listed IRMD is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of IRMD?
Chris Williamson
| Executive Vice President of Continuous Improvement & Information Technology
John F. Glenn
| Chief Financial Officer & Corporate Secretary
Lynn Neuhardt
| Vice President of Research & Development
Randy Waddell
| Vice President of Worldwide Sales & Marketing
Roger E. Susi
| Founder, Chairman, Chief Executive Officer & President
How many employees does IRMD have?
Number of IRMD employees currently stands at 166. IRMD operates from 1025 Willa Springs Drive, Orlando, FL 32826, US.
Link for IRMD official website?
Official Website of IRMD is: https://www.iradimed.com
How do I contact IRMD?
IRMD could be contacted at phone #407 677 8022 and can also be accessed through its website. IRMD operates from 1025 Willa Springs Drive, Orlando, FL 32826, US.
How many shares of IRMD are traded daily?
The average number of IRMD shares traded daily for last 3 months was 134.76K.
What is the market cap of IRMD currently?
The market value of IRMD currently stands at $1.17B with its latest stock price at $91.21